Hour24 News
Sophisticated and simple
-
Arkin Capital doubles down on early clinical science Arkin Capital has unveiled Arkin Bio Ventures III, a new $100 million biotech fund dedicated to advancing…
-
Arkin Capital Bets on Early Clinical Biotech with a $100 Million Fund In a move that underscores a distinct approach within the crowded life sciences…
